|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||39.53 - 39.85|
|52-week range||39.53 - 39.85|
|Beta (5Y monthly)||0.84|
|PE ratio (TTM)||N/A|
|Earnings date||28 Apr 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
In this article we are going to estimate the intrinsic value of Boston Scientific Corporation ( NYSE:BSX ) by taking...
Boston Scientific's (BSX) TheraSphere is expected to be used as a safe and effective treatment option for numerous HCC patients worldwide on the back of positive trial results.
DaVita's (DVA) recent collaboration will help patients benefit from the portability, dependability and flexibility of NxStage home machines, designed to be easy to use.